BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7443475)

  • 1. [Familial hypercholesterolemic xanthomatosis: effect of colestipol on the lipoprotein profile].
    Drouin P; Sauvanet JP; Demange J; Lambert L; Debry G
    Nouv Presse Med; 1980 Nov; 9(42):3186. PubMed ID: 7443475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
    Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
    Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
    [No Abstract]   [Full Text] [Related]  

  • 3. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
    Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
    Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
    Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
    Kusić M; Gavrilović M; Mihajlović M; Bosković B
    Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride.
    Witztum JL; Jacobs LS; Schonfeld G
    J Clin Endocrinol Metab; 1978 May; 46(5):838-40. PubMed ID: 262768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
    Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
    Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
    Kuo PT; Kostis JB; Moreyra AE; Hayes JA
    Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
    Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
    Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
    Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
    Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid.
    Kuo PT; Toole JF; Schaaf JA; Jones A; Wilson AC; Kostis JB; Moreyra AE
    Stroke; 1987; 18(4):716-21. PubMed ID: 3299882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 25-hydroxy-vitamin D in familial hypercholesterolemic children receiving colestipol resin.
    Tsang RC; Roginsky MS; Mellies MJ; Glueck CJ
    Pediatr Res; 1978 Oct; 12(10):980-2. PubMed ID: 724301
    [No Abstract]   [Full Text] [Related]  

  • 17. Colestipol tablets in adolescents with familial hypercholesterolaemia.
    Tonstad S; Ose L
    Acta Paediatr; 1996 Sep; 85(9):1080-2. PubMed ID: 8888922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of coronary atherosclerosis in man.
    Myant NB
    Adv Exp Med Biol; 1984; 168():139-52. PubMed ID: 6375296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adrenocortical functions in hypercholesterolemic patients; effect of long-term treatment with colestipol-HCl (author's transl)].
    Morimoto Y
    Horumon To Rinsho; 1981 Feb; 29(2):237-43. PubMed ID: 7261445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
    Düntsch G
    Fortschr Med; 1981 Jan; 99(3):73-5. PubMed ID: 6781999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.